Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Open-market buy 10% owner bought 7,500,000 shares at $0.67 ($5,000,250)
  2. 4 Open-market buy Director bought 7,500,000 shares at $0.67 ($5,000,250)
  3. 4 Open-market buy 10% owner bought 7,500,000 shares at $0.67 ($5,000,250)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale Chief Medical Officer sold 911 shares at $5.13 ($4,678)
  10. 4 Open-market sale Chief Operating Officer sold 2,397 shares at $5.13 ($12,308)
  11. 4 Open-market sale Chief Business Officer sold 100,000 shares at an average $4.50 ($450,000)
  12. 4 Open-market sale Chief Patient Supply Officer sold 1,144 shares at $5.13 ($5,874)
  13. 4 Open-market sale Chief Executive Officer sold 3,236 shares at $5.13 ($16,616)
  14. 4 Open-market sale Director sold 300,000 shares at an average $4.67 ($1,400,000)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale Chief Patient Supply Officer sold 1,148 shares at $1.20 ($1,378)
  17. 4 Open-market sale Chief Operating Officer sold 3,731 shares at $1.20 ($4,477)
  18. 4 Open-market sale Chief Executive Officer sold 5,900 shares at $1.20 ($7,080)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 10 of 18 · 351 filings